DrugPatentWatch Database Preview

Details for Patent: 7,919,483

Email this page to a colleague

« Back to Dashboard

Which drugs does patent 7,919,483 protect, and when does it expire?

Patent 7,919,483 protects XIMINO and SOLODYN and is included in two NDAs.

This patent has thirteen patent family members in ten countries.

Summary for Patent: 7,919,483

Title:	Method for the treatment of acne
Abstract:	A method for treatment of acne with tetracyclines is provided. A lower sustained dose and no loading dose is employed, with an optional once-a-day dosing regimen.
Inventor(s):	Wortzman; Mitchell (Scottsdale, AZ), Plott; R. Todd (Briscoe, TX), Bhatia; Kuljit (Nesconset, NY), Patel; Bhiku (Chandler, AZ)
Assignee:	Medicis Pharmaceutical Corporation (Scottsdale, AZ)
Application Number:	11/166,817
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,919,483
Patent Claim Types: see list of patent claims	Use; Composition; Dosage form; Delivery;

Drugs Protected by US Patent 7,919,483

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Journey	XIMINO	minocycline hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	201922-001	Jul 11, 2012		RX	No	No						TREATMENT OF ACNE
Journey	XIMINO	minocycline hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	201922-003	Jul 11, 2012		RX	No	No						TREATMENT OF ACNE
Journey	XIMINO	minocycline hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	201922-005	Jul 11, 2012		RX	No	No						TREATMENT OF ACNE
Bausch	SOLODYN	minocycline hydrochloride	TABLET, EXTENDED RELEASE;ORAL	050808-001	May 8, 2006		DISCN	Yes	No						TREATMENT OF ACNE
Bausch	SOLODYN	minocycline hydrochloride	TABLET, EXTENDED RELEASE;ORAL	050808-008	Aug 27, 2010	AB	RX	Yes	No						TREATMENT OF ACNE
Bausch	SOLODYN	minocycline hydrochloride	TABLET, EXTENDED RELEASE;ORAL	050808-004	Jul 23, 2009	AB	RX	Yes	No						TREATMENT OF ACNE
Bausch	SOLODYN	minocycline hydrochloride	TABLET, EXTENDED RELEASE;ORAL	050808-007	Aug 27, 2010	AB	RX	Yes	No						TREATMENT OF ACNE

International Family Members for US Patent 7,919,483

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2006262428
Canada	2613273
China	101208097
European Patent Office	1898925
Israel	188331
Japan	2008543936
Japan	2013213047